UK employers are facing more employment tribunal claims involving ADHD and autism as awareness, diagnosis rates and expectations around reasonable adjustments rise. A Lidl case awarded Ryan Toghill more than £45,000 after the tribunal found his ADHD was not properly considered.
An AI tool, AI Consult, powered by GPT-4o, was tested in Kenyan primary clinics, helping clinical officers like Vyonne Njeri improve diagnoses and treatment plans, though patient outcome improvement was not statistically significant.
An external audit of UnitedHealth's HouseCalls unit found 97% of diagnoses were supported by patient records. The audit, commissioned by UnitedHealth, addressed scrutiny from lawmakers over diagnoses not appearing elsewhere in patient histories, which influence Medicare Advantage payments. 3.4% of diagnoses lacked support.
Hong Kong researchers are developing an affordable blood test for prostate cancer, aiming to reduce the need for invasive biopsies. The technology is expected to launch in about two years, offering a less uncomfortable diagnostic process for patients like Peter Wan, who experienced a lengthy and invasive journey to his diagnosis.
Endometriosis diagnoses in Rhineland-Palatinate have increased by 82% over 20 years, reaching approximately 22,500 cases in 2024. Increased societal awareness is cited as a key reason for the rise, reducing diagnostic uncertainty for affected women.
Experts warn misinformation about perimenopause on social media is leading women to stop contraception, seek unnecessary HRT, and miss serious diagnoses. Many younger women are being misled into believing they are menopausal when they are still fertile, risking unintended pregnancies and incorrect treatments.
Parents of a five-year-old girl with a serious heart defect, missed by prenatal scans, stress the importance of early diagnosis. Esme required life-saving surgery for Atrioventricular Septal Defect (AVSD). Health boards expressed regret and offered to discuss concerns.
Polycystic Ovary Syndrome (PCOS), affecting over 3 million UK women, is renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) to reflect its complex hormonal nature, aiming to improve diagnoses and treatment.
Alzheimer’s Research UK says patients at risk of being left behind as lack of formal or accurate diagnoses closes door to trialsPeople with Alzheimer’s disease are missing out on experimental treatments because they are not diagnosed early or accurately enough to be enrolled in clinical trials, a UK charity has said.Trials of Alzheimer’s drugs reached a record high this year, according to data published on Tuesday, but Alzheimer’s Research UK said too few UK patients were taking part because their diagnoses were delayed or were not specific enough. Continue reading...
A new study in Science from Harvard Medical School and Beth Israel Deaconess Medical Center finds OpenAI's o1 model matched or exceeded attending physicians in diagnosing 76 emergency room patients. At initial triage, o1 provided exact or very close diagnoses 67% of the time vs. 55% and 50% for two physicians. Researchers stress AI is not ready for real clinical use and call for prospective trials.
The pet fitness tracker market is projected to grow to $450m (£333m) by 2035, but veterinary experts are divided on their value. While owners like Bryan Becker credit the devices with helping manage his anxious dog's medication dosage, Dr Elizabeth Mullineaux of the British Veterinary Association warns they are costly and could cause needless worry. Supporters argue pets hide pain instinctively and trackers enable early intervention, while critics emphasise that day-to-day observations and veterinary expertise remain essential.
